Eton Pharmaceuticals Inc ETON:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
3.43UNCH (UNCH)
Volume
139,021
52 week range
2.42 - 5.81
Loading...
  • Open3.70
  • Day High3.70
  • Day Low3.30
  • Prev Close3.44
  • 52 Week High5.81
  • 52 Week High Date09/15/23
  • 52 Week Low2.42
  • 52 Week Low Date07/31/23

Key Stats

  • Market Cap88.11M
  • Shares Out25.69M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change-21.69

KEY STATS

  • Open3.70
  • Day High3.70
  • Day Low3.30
  • Prev Close3.44
  • 52 Week High5.81
  • 52 Week High Date09/15/23
  • 52 Week Low2.42
  • 52 Week Low Date07/31/23
  • Market Cap88.11M
  • Shares Out25.69M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.27
  • YTD % Change-21.69

RATIOS/PROFITABILITY

  • EPS (TTM)0.04
  • P/E (TTM)97.17
  • Fwd P/E (NTM)-68.60
  • EBITDA (TTM)-291,000.009
  • ROE (TTM)-6.56%
  • Revenue (TTM)31.642M
  • Gross Margin (TTM)66.56%
  • Net Margin (TTM)-2.96%
  • Debt To Equity (MRQ)34.76%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Eton Pharmaceuticals Inc

 

Profile

MORE
Eton Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing treatments for rare diseases. The Company has five commercial rare disease products: ALKINDI SPRINKLE, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector. ALKINDI SPRINKLE is a granule hydrocortisone formulation designed...
Norbert Riedel Ph.D.
Independent Chairman of the Board
Sean Brynjelsen
President, Chief Executive Officer, Director
James Gruber
Chief Financial Officer, Treasurer, Company Secretary
Address
21925 W Field Pkwy Ste 235
Deer Park, IL
60010-7278
United States

Top Peers

SYMBOLLASTCHG%CHG
ELUT
Elutia Inc
3.28+0.48+17.14%
CASI
CASI Pharmaceuticals Inc
2.64+0.02+0.65%
CPIX
Cumberland Pharmaceuticals Inc
1.68-0.06-3.45%
BFRI
Biofrontera Inc
1.26-0.32-20.25%
RLMD
Relmada Therapeutics Inc
3.54-0.26-6.97%